Supplemental Data for A Phase II Study of Talazoparib Tosylate in Advanced Cancer Patients with Somatic and Germline (Not Breast or Ovarian Cancer) Alterations of BRCA1/2, Mutations/Deletions/Amplification in Other Homologous Recombination Repair Pathway Genes and PTEN or PTEN loss

Authors

• Sarina A. Piha-Paul, The University of Texas MD Anderson Cancer Center
• Chieh Tseng, The University of Texas MD Anderson Cancer Center
• Cheuk Hong Leung, The University of Texas MD Anderson Cancer Center
• Ying Yuan, The University of Texas MD Anderson Cancer Center
• Daniel D. Karp, The University of Texas MD Anderson Cancer Center
• Vivek Subbiah, The University of Texas MD Anderson Cancer Center
• David Hong, The University of Texas MD Anderson Cancer Center
• Siqing Fu, The University of Texas MD Anderson Cancer Center
• Aung Naing, The University of Texas MD Anderson Cancer Center
• Jordi Rodon, The University of Texas MD Anderson Cancer Center
• Milind Javle, The University of Texas MD Anderson Cancer Center
• Jaffer Ajani, The University of Texas MD Anderson Cancer Center
• Kanwal Raghav, The University of Texas MD Anderson Cancer Center
• Neeta Somaiah, The University of Texas MD Anderson Cancer Center
• Gordon B. Mills, Knight Cancer Institute
• Apostolia Tsimberidou, The University of Texas MD Anderson Cancer Center
• Xiaofeng Zheng, The University of Texas MD Anderson Cancer Center
• Ken Chen, The University of Texas MD Anderson Cancer Center
• Funda Meric-Bernstam, The University of Texas MD Anderson Cancer Center

Files

Data Availability

The de-identified participant data and dataset generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

Custom code that was used in the generation or analysis of the datasets is available upon reasonable request.

Corresponding Author: Sarina Piha-Paul,Department of Investigational Cancer Therapeutics (A Phase I Clinical Trials Program), University of Texas MD Anderson Cancer Center, Houston, TX. Phone: (713)-563-1055, Fax:(713)-792-3535, spihapau@mdanderson.org.

DOI

https://doi.org/10.52519/00133

Publication Date

6-2024

Publisher

The University of Texas MD Anderson Cancer Center

Recommended Citation

Piha-Paul, Sarina A.; Tseng, Chieh; Hong Leung, Cheuk; Yuan, Ying; Karp, Daniel D.; Subbiah, Vivek; Hong, David; Fu, Siqing; Naing, Aung; Rodon, Jordi; Javle, Milind; Ajani, Jaffer; Raghav, Kanwal; Somaiah, Neeta; Mills, Gordon B.; Tsimberidou, Apostolia; Zheng, Xiaofeng; Chen, Ken; and Meric-Bernstam, Funda, "Supplemental Data for A Phase II Study of Talazoparib Tosylate in Advanced Cancer Patients with Somatic and Germline (Not Breast or Ovarian Cancer) Alterations of BRCA1/2, Mutations/Deletions/Amplification in Other Homologous Recombination Repair Pathway Genes and PTEN or PTEN loss" (2024). Division of Investigational Cancer Therapeutics. 1.
doi:https://doi.org/10.52519/00133